Core Viewpoint - Yongsheng Medical Holdings Limited has announced multiple related party transaction agreements, including lease renewals and service agreements, which are expected to benefit the company and its shareholders [1]. Group 1: Financial Performance - As of December 16, 2025, Yongsheng Medical's stock closed at HKD 0.81, down 2.41% from the previous trading day, with a trading volume of HKD 153,300 [1]. - The stock has seen a 52-week high of HKD 1.29 and a low of HKD 0.33 [1]. Group 2: Related Party Transactions - The company has entered into lease renewal agreements with related parties VRDL and VRDG for properties in Hong Kong and China, with a total asset confirmation of approximately HKD 21.6 million [1]. - The lease terms are set from January 1, 2026, to December 31, 2027, with annual caps of HKD 7 million for 2026 and HKD 8 million for 2027, which will be combined with existing healthcare product procurement agreements [1]. - Additionally, a service renewal agreement for plastic and metal parts supply and processing services has been established with VRDG, effective for the same period [1].
永胜医疗（01612.HK）披露关连交易及持续关连交易重续协议，12月16日股价下跌2.41%